HIGH-DOSE CISPLATIN IN HYPERTONIC SALINE - REDUCED TOXICITY OF A MODIFIED DOSE SCHEDULE AND CORRELATION WITH PLASMA PHARMACOKINETICS - A NORTHERN CALIFORNIA ONCOLOGY GROUP PILOT-STUDY IN NON-SMALL-CELL LUNG-CANCER

被引：70

作者：

GANDARA, DR

DEGREGORIO, MW

WOLD, H

WILBUR, BJ

KOHLER, M

LAWRENCE, HJ

DEISSEROTH, AB

GEORGE, CB

机构：

[1] NO CALIF ONCOL GRP,PALO ALTO,CA

[2] UNIV CALIF DAVIS,DIV HEMATOL ONCOL,DAVIS,CA 95616

[3] UNIV CALIF SAN FRANCISCO,CANC RES INST,SAN FRANCISCO,CA 94143

[4] LETTERMAN ARMY INST RES,SERV HEMATOL ONCOL,SAN FRANCISCO,CA 94129

[5] UNIV CALIF SAN FRANCISCO,DIV HEMATOL ONCOL,SAN FRANCISCO,CA 94143

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1986年 / 4卷 / 12期

关键词：

D O I：

10.1200/JCO.1986.4.12.1787

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：1787 / 1793

页数：7

相关论文

共 23 条

[1] A HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY WITH IMPROVED SELECTIVITY FOR CISPLATIN AND ACTIVE PLATINUM(II) COMPLEXES IN PLASMA ULTRAFILTRATE
ANDREWS, PA
WUNG, WE
HOWELL, SB
[J]. ANALYTICAL BIOCHEMISTRY, 1984, 143 (01) : 46 - 56
[2] BRUCKNER HW, 1981, GYNECOL ONCOL, V12, P61
[3] CLINICAL-PHARMACOLOGY OF HIGH-DOSE CISPLATIN
CORDEN, BJ
FINE, RL
OZOLS, RF
COLLINS, JM
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 14 (01) : 38 - 41
[4] CROWLEY T, 1985, P AM ASSOC CANC RES, V26, P156
[5] DEGREGORIO MW, 1985, CANCER CHEMOTH PHARM, V15, P183
[6] DEGREGORIO MW, 1985, CANCER TREAT REP, V69, P1441
[7] CIS-DIAMMINEDICHLOROPLATINUM, VINBLASTINE, AND BLEOMYCIN COMBINATION CHEMOTHERAPY IN DISSEMINATED TESTICULAR CANCER
EINHORN, LH
DONOHUE, J
[J]. ANNALS OF INTERNAL MEDICINE, 1977, 87 (03) : 293 - 298
[8] CURRENT CONCEPTS IN CANCER - ROLE OF CIS-PLATINUM IN SOLID-TUMOR THERAPY
EINHORN, LH
WILLIAMS, SD
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (06) : 289 - 291
[9] HAYES DM, 1977, CANCER, V39, P1372, DOI 10.1002/1097-0142(197704)39:4<1372::AID-CNCR2820390404>3.0.CO
[10] 2-J